Effect of exogenous prostaglandin E2 on plasma antidiuretic hormone in normal man. Role of angiotension II.
To verify if exogenous prostaglandin E2 (PGE2) is able to release antidiuretic hormone (ADH) and if endogenous angiotensin II plays a role in this eventual PGE2-induced stimulation of vasopressin, increasing doses of PGE2 were infused in 6 normal volunteers before (PGE2 study) and after the administration of 100 mg of captopril (captopril study). PGE2, even at an infusion rate of 40 and 60 ng/kg/min, did not modify blood pressure when it was infused alone; a significant fall of blood pressure was observed, in contrast, in the captopril study. PGE2 alone doubled the plasma levels of ADH. One hour after the subjects had been pre-treated with captopril, plasma levels of ADH fell by about 38%, then they increased by about 60% during the infusion of PGE2. These results suggest that in normal man endogenous angiotensin II is an important non-osmotic regulator of plasma ADH and that exogenous PGE2 can stimulate maximally the release of ADH only when the renin-angiotensin system is not impaired.
Usberti
M
M
Ospedale di Leno, Istituto di Chimica, Università di Brescia, Italy.
Gargiulo
A
A
Comberti
E
E
Campisi
S
S
Poiesi
C
C
Brognoli
M
M
Doregatti
C
C
Rondina
M
M
Zaneboni
A
A
Ghielmi
S
S
D000328:Adult; D000450:Aldosterone / Q000097:blood; D000527:Alprostadil / Q000097:blood / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology; D002395:Catecholamines / Q000652:urine; D004359:Drug Therapy, Combination; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D011863:Radioimmunoassay; D012083:Renin / Q000097:blood; D014667:Vasopressins / Q000097:blood*
D002395:Catecholamines; D014667:Vasopressins; D000450:Aldosterone; D002216:Captopril; D012083:Renin; D000527:Alprostadil